LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 1311 | 2498 | 5079 | 0.4919 | 0.3898 |
MDA-MB-231 | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 1311 | 2483 | 4935 | 0.5031 | 0.3960 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1593 | 5079 | 0.3139 | 0.1044 |
MDA-MB-231 | Radicicol | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1606 | 4935 | 0.3257 | 0.1117 |
MDA-MB-231 | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1193 | 5079 | 0.2350 | -0.0475 |
MDA-MB-231 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1216 | 4935 | 0.2464 | -0.0390 |
MDA-MB-231 | Radicicol | 10 | uM | LJP5 | 72 | hr | 1311 | 1236 | 5079 | 0.2435 | -0.0298 |
MDA-MB-231 | Radicicol | 10 | uM | LJP6 | 72 | hr | 1311 | 1256 | 4935 | 0.2545 | -0.0227 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP5 | 72 | hr | 1311 | 5106 | 5079 | 1.0052 | 1.0049 |
MDA-MB-231 | Withaferin A | 0.04 | uM | LJP6 | 72 | hr | 1311 | 4878 | 4935 | 0.9882 | 0.9868 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4805 | 5079 | 0.9462 | 0.9437 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4866 | 4935 | 0.9862 | 0.9855 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4318 | 5079 | 0.8501 | 0.8402 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP6 | 72 | hr | 1311 | 3880 | 4935 | 0.7865 | 0.7629 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1384 | 5079 | 0.2728 | 0.0276 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1295 | 4935 | 0.2626 | -0.0068 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1037 | 5079 | 0.2043 | -0.1133 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1311 | 810 | 4935 | 0.1642 | -0.2233 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 72 | hr | 1311 | 466 | 5079 | 0.0916 | -0.4133 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP6 | 72 | hr | 1311 | 379 | 4935 | 0.0770 | -0.4802 |
BT-20 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1334 | 4094 | 4033 | 1.0156 | 1.0199 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4007 | 4033 | 0.9941 | 0.9928 |
BT-20 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1334 | 3825 | 4033 | 0.9490 | 0.9358 |
BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3827 | 4033 | 0.9489 | 0.9352 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3442 | 4033 | 0.8529 | 0.8091 |